SynBiotic SE

SynBiotic SE

News

10.01.2025 11:44:28

EQS-News: SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025

18.12.2024 13:06:47

EQS-News: Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis

18.12.2024 09:01:01

Original-Research: SYNBIOTIC SE (von NuWays AG): BUY

25.11.2024 11:39:58

EQS-News: SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry

14.11.2024 13:30:41

EQS-News: In full bloom: WEECO Pharma boosts SYNBIOTIC's sales

27.09.2024 11:19:23

EQS-News: Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval

17.09.2024 09:01:14

Original-Research: SynBiotic SE (von NuWays AG): BUY

16.08.2024 12:30:07

EQS-News: SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth

23.05.2024 10:31:25

EQS-News: Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow

08.05.2024 14:27:26

EQS-News: Acquisition of WEECO Pharma: SYNBIOTIC significantly expands its position in the medical cannabis market

Downloads

Latest Research

Initiation

Analyst

Christian Sandherr

Equity Research

Latest Research

Christian Sandherr

December 18 2024

18 Dec 24

The new group continues to take shape; chg. est.

Christian Sandherr

September 17 2024

17 Sep 24

SynBiotic transformation: Reaching new operational high(t)s

Christian Sandherr

August 29 2023

29 Aug 23

Gearing up to capitalize on favorable market dynamics; chg.

Christian Sandherr

December 28 2022

28 Dec 22

Strategic realignment to capitalize on cannabis legalization; chg.